Infectious Diseases and Vaccines

Keep up with the pace of infectious 
diseases

Infectious Disease research is a dynamic space requiring nimble and innovative solutions. Our team of infectious diseases and vaccines experts respond to the need for speed and flexibility through novel trial design and technology solutions that allow for real-time data delivery.

Expedited protocols and proven success.

COVID may have been unprecedented, but our vaccine experience, sit solutions, systems, process, tools and support meant we were ready, and will continue to be.

  • 400k direct-to-patient
  • 105K+ patients enrolled in vaccine trials within 4-6 weeks per trial
  • 1.7X meaningfully high inclusion of diverse populations enrolled in COVID-19 vaccine trials versus peers

Revolutionizing global pandemic response speeds

Our advanced analytics includes real-time simulation of active cases, near real time surveillance and impact analysis. Plus, expertise in influenza and COVID-19, clinical trial acceleration and advance response time and vaccine development.

We have diverse teams with experience in over 400 trials in more than 90 countries, excluding COVID-19 trials, in the last 10 years.

Industry leader with robust data and innovation

Our expertise covers drug and interventional vaccine development, immunization for high-risk groups, and severe RSV case management including infants and adults; additional experience in respiratory health.

Revolutionizing Hepatitis B trials

With cutting-edge diagnostic testing, global expertise and advanced technologies, and decades of experience, our solutions ensure high-quality infrastructure and precise HBV testing, driving impactful results and healthcare advancements.

Groundbreaking Tuberculosis work in Africa

Our extensive experience includes collaboration with local authorities, supporting development of strong laboratory networks and services, has revolutionized treatment, saving lives and transforming public health outcomes.

Innovate HIV care backed by analytics, tech and experience

With our integration of advanced analytics, real-world evidence and technology, we support life-changing therapies and enhance global HIV care. Combined with our decades of experience, we drive innovative solutions, improving patient outcomes.

Experience and expertise

It is an increasingly diverse and dynamic environment with new and re-emerging pathogens. The study of infectious diseases and vaccines is as complex as the populations and environments they impact. Timing of treatment and protection is critical for seasonal preparedness or pandemic relief.

Our global IQVIA specialized team of scientific, medical, and operational experts can design and deliver complex clinical
trials by

  • Strategizing adaptive trial designs
  • Overcoming recruitment barriers and obstacles
  • Enhancing productivity at investigative sites
  • Utilizing tailored solutions to accelerate timelines without sacrificing data quality

Strategies and solutions for every trial

IQVIA supports sponsors of every size and at every stage, including government and nonprofit organizations, to advance broader public health goals. IQVIA is a Global Health Clinical Consortium partner and has conducted BARDA, NIH, and CEPI funded trials. We have delivered trials in disease areas from influenza, anthrax, and Ebola to acute radiation syndrome and nerve agent countermeasures. We understand clinical development challenges and offer strategies and solutions to address your specific and unique trial needs.

When speed and agility matters

Navigating the nuances of infectious diseases requires having the right resources at the right time in order to meet critical timelines. A partner with global presence and proven record is a must. IQVIA integrates unparalleled data and transformative technology, making intelligent connections to help you.

  • Identify and enroll patients globally, including hard-to-find populations in China, Asia Pacific, Africa, and the Middle East
  • Design and execute innovative trial designs
  • Use AI to optimize site selection during pandemics and seasonal outbreaks
  • Improve patient experience and data quality with decentralized trials, eCOA, and eConsent

Solutions you may be interested in

Contact Us